Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
Follow MTD
Mettler-Toledo International, Inc. (MTD) EV/EBITDA
As of 16 October 2026, Mettler-Toledo International, Inc. (MTD) trades at a EV/EBITDA of 26.6×. Over the past ten years it has ranged from 14.8× (October 2015) to 37.9× (December 2021); the current reading is higher than 74% of that period. That is above the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 24.8× | 10.92% |
| FY2024 | 22.3× | (6.02%) |
| FY2023 | 23.8× | (15.37%) |
| FY2022 | 28.1× | (24.17%) |
| FY2021 | 37.0× | 14.87% |
| FY2020 | 32.2× | 28.04% |
| FY2019 | 25.2× | 27.85% |
| FY2018 | 19.7× | (20.20%) |
| FY2017 | 24.7× | 25.29% |
| FY2016 | 19.7× | 12.70% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Jun 2026 | 21.3× | (3.86%) |
| Mar 2026 | 22.1× | (10.68%) |
| Dec 2025 | 24.8× | 11.76% |
| Sep 2025 | 22.2× | 2.28% |
| 42 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 14.1× |
| LH Labcorp Holdings Inc. compare | 14.5× |
| IQV IQVIA Holdings Inc. compare | 17.1× |
| A Agilent Technologies, Inc. compare | 26.5× |
| MTD Mettler-Toledo International, Inc. | 26.6× |
| IDXX IDEXX Laboratories, Inc. compare | 27.6× |
| ILMN Illumina, Inc. compare | 35.0× |
| WAT Waters Corporation compare | 50.1× |
| Diagnostics & Research industry median | 24.3× |
| Healthcare sector median | 9.2× |
| Market median | 11.0× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on MTD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement